Answers are grounded in this paper and cite their sources.
Introduction: In Madagascar, coverage of the optimal dose (three doses or more) of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during pregnancy (IPTp-SP) remains low, reaching only 31% in 2021. This study aimed to investigate the factors influencing this low coverage in a particularly affected community. Methods: This was a cross-sectional study using a mixed-methods approach, conducted among mothers with a child under 12 months and healthcare personnel in Farafangana from November 19, 2024, to January 10, 2025. A descriptive analysis, a bivariate and multivariate logistic regression, were conducted. The odds ratio with a 95% confidence interval was used as the measure of association. Qualitative data analysis was conducted manually based on predefined themes and sub-themes. Results: The coverage of the optimal dose of IPTp-SP was 28.9%. Factors significantly associated with the non-receipt of the optimal dose included women under 25 years of age (adjusted odds ratios (AOR) [95% confidence intervals (CI)] = 0.47 [0.26 – 0.83]), being multigravida (AOR [95% CI] = 1.66 [1.08 – 3.14]), multiparity (AOR [95% CI] = 1.62 [1.13 – 3.18]), poor knowledge of the recommended dose (AOR [95% CI] = 6.82 [3.21 – 14.49]), late initiation of intake (AOR [95% CI] = 2.28 [1.41 – 3.67]), and SP-related side effects (AOR [95% CI] = 1.58 [1.02 – 2.46]). The qualitative approach corroborated these findings and identified the influence of women’s social surroundings. Conclusion: Factors related to women, sociocultural aspects, and the health system influence the low coverage of the optimal IPTp-SP dose in Farafangana. An implementation approach addressing all these factors would be essential to improve coverage.
No takes yet. Share an insight, caveat, or question.
Miraimila et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: